1. Home
  2. BLCO vs LNC Comparison

BLCO vs LNC Comparison

Compare BLCO & LNC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BLCO
  • LNC
  • Stock Information
  • Founded
  • BLCO 1853
  • LNC 1905
  • Country
  • BLCO Canada
  • LNC United States
  • Employees
  • BLCO N/A
  • LNC N/A
  • Industry
  • BLCO Ophthalmic Goods
  • LNC Life Insurance
  • Sector
  • BLCO Health Care
  • LNC Finance
  • Exchange
  • BLCO Nasdaq
  • LNC Nasdaq
  • Market Cap
  • BLCO 4.9B
  • LNC 5.5B
  • IPO Year
  • BLCO 2022
  • LNC N/A
  • Fundamental
  • Price
  • BLCO $13.99
  • LNC $34.06
  • Analyst Decision
  • BLCO Hold
  • LNC Hold
  • Analyst Count
  • BLCO 13
  • LNC 10
  • Target Price
  • BLCO $15.83
  • LNC $38.00
  • AVG Volume (30 Days)
  • BLCO 785.5K
  • LNC 2.1M
  • Earning Date
  • BLCO 07-30-2025
  • LNC 07-31-2025
  • Dividend Yield
  • BLCO N/A
  • LNC 5.28%
  • EPS Growth
  • BLCO N/A
  • LNC N/A
  • EPS
  • BLCO N/A
  • LNC 7.17
  • Revenue
  • BLCO $4,829,000,000.00
  • LNC $18,544,000,000.00
  • Revenue This Year
  • BLCO $6.97
  • LNC $5.40
  • Revenue Next Year
  • BLCO $5.48
  • LNC $1.72
  • P/E Ratio
  • BLCO N/A
  • LNC $4.75
  • Revenue Growth
  • BLCO 11.94
  • LNC 54.56
  • 52 Week Low
  • BLCO $10.45
  • LNC $27.58
  • 52 Week High
  • BLCO $21.69
  • LNC $39.85
  • Technical
  • Relative Strength Index (RSI)
  • BLCO 69.08
  • LNC 51.20
  • Support Level
  • BLCO $12.02
  • LNC $34.06
  • Resistance Level
  • BLCO $14.35
  • LNC $35.49
  • Average True Range (ATR)
  • BLCO 0.46
  • LNC 0.86
  • MACD
  • BLCO 0.15
  • LNC 0.00
  • Stochastic Oscillator
  • BLCO 85.82
  • LNC 60.13

About BLCO Bausch + Lomb Corporation

Bausch & Lomb is one of the largest vision care companies in the US. The firm was previously a subsidiary under parent company Bausch Health and it was spun off to become a public company in 2022. It operates in three segments: vision care, surgical, and ophthalmic pharmaceuticals. Vision care is composed of contact lenses, a market that B&L controls 10%, and ocular health products, which includes Biotrue and Lumify. Surgical includes a suite of intraocular lenses, equipment for cataract and vitreoretinal surgeries, as well as surgical instruments. Ophthalmic pharmaceuticals has a diverse lineup of products, including Xipere, Vyzulta, and Lotemax that treat different complications. With over 100 products, B&L has the largest portfolio of eye care prescriptions in the space.

About LNC Lincoln National Corporation

Lincoln National Corp operates multiple insurance and retirement businesses. The company's operating segment includes Annuities; Retirement Plan Services; Life Insurance and Group Protection. Its products include fixed and indexed annuities, variable annuities, universal life insurance (UL), variable universal life insurance (VUL), linked-benefit UL and VUL, indexed universal life insurance (IUL), term life insurance, employer-sponsored retirement plans and services, and group life, disability and dental.

Share on Social Networks: